Not long ago, as attention centered on the Senate Finance Committee's moderate health- care reform bill, pundits dismissed the idea of a publicly run insurance program to compete with private insurers as all but dead. Now, as Senate leaders are close to merging that bill with a more liberal alternative passed earlier in the summer, the public option—a sort of Medicare for the masses—appears to be making a comeback.
In one sense, it's small surprise: While the Finance Committee explicitly rejected the public option, some version of the idea featured prominently in other major reform bills pending in the House and Senate. The Senate is expected to come up with its merged bill in the next week or so, and the House will deliver its own unified legislation soon after. Then the real jousting will begin.
Andy Laperriere, a policy analyst for International Strategy & Investment, has said for weeks that a public health plan remained on the table. "The base case has been that there isn't going to be a public plan, but it remains a real possibility," he says.
Less clear, however, is just what shape the public option may take and how extensive it will be in any final legislation to pass Congress. "What will materialize is likely to be some sort of plan that both puts some pressure on insurance companies to compete, but isn't seen as a real threat to insurance companies," John Shepard, a policy analyst with Concept Capital's Washington Research Group, wrote in a recent report to investors.
Support for the concept generally runs strong among Democrats in Congress and with the public as well, some polls suggest. A Washington Post/ABC poll published on Oct. 20 found that support for a public option has increased since the summer, with 57% of all Americans now favoring a public insurance option and 40% opposing it.
House Speaker Nancy Pelosi (D-Calif.) has said she can count on some 200 votes and expects to get more. (She needs 218). President Barack Obama has long backed the idea, though of late his aides have made clear it wouldn't be a deal breaker if the bill that finally reaches his desk doesn't contain a public plan.
The Senate is another matter. Practically speaking, Democrats must deliver all 60 of the party's votes in the chamber or recruit moderate Republicans to overcome the risk of a filibuster or other procedural maneuvers. Senator Olympia Snowe (R-Me.), the lone Republican so far to vote for any of the pending bills in committee, has balked at supporting a government-run plan without significant strings, such as a trigger-activated plan. And conservative Democrats are under intense pressure to vote against a public plan, thanks to enormous opposition from health insurers and other medical providers, as well as business lobbies like the U.S. Chamber of Commerce and the National Association of Manufacturers. Many also come from red states—or traditionally Republican Congressional districts—where opposition to an increased government hand in health care runs strong.
But a public plan could come in many flavors. On the aggressive end, Pelosi favors a "robust" version—a full-fledged government-sponsored plan that competes head-to-head with private-sector plans and pays hospitals and doctors 5% above Medicare's rates. Insurers hotly oppose such an idea. Among other problems, says Karen Ignagni, the head of America's Health Insurance Plans, the industry lobby, it would "bankrupt the hospital industry." She argues the measure would also cause hospitals and doctors to shift costs for which they weren't reimbursed over to private insurers, forcing them to raise their rates.
Track and share business topics across the Web.